|
Real-world treatment landscape in advanced metastatic castration resistant prostate cancer. |
| |
|
Employment - Alnylam (I); Johnson & Johnson |
Stock and Other Ownership Interests - Alnylam (I) |
Research Funding - Alnylam; Johnson & Johnson |
| |
|
Stock and Other Ownership Interests - JJ Innovative Medicine |
| |
|
Employment - JJ Innovative Medicine |
Stock and Other Ownership Interests - JJ Innovative Medicine |
Research Funding - JJ Innovative Medicine |
Travel, Accommodations, Expenses - JJ Innovative Medicine |
| |
|
Employment - Johnson Johnson Innovative Medicine |
| |
|
Employment - JJ Innovative Medicine |
Stock and Other Ownership Interests - JJ Innovative Medicine |
Research Funding - JJ Innovative Medicine |
| |
|
Employment - Johnson & Johnson, Merck |
Stock and Other Ownership Interests - Johnson & Johnson, Merck |
| |
|
No Relationships to Disclose |
| |
|
Employment - JJ Innovative Medicine |
Stock and Other Ownership Interests - JJ Innovative Medicine |